A 52-year-old woman with chronic gastroesophageal reflux disease (GERD) for 15 years undergoes upper endoscopy for persistent dysphagia. Endoscopy reveals a salmon-pink patch in the distal esophagus replacing the normal pale squamous mucosa. Biopsy from this area shows columnar epithelium with intestinal-type mucosa containing goblet cells, but the epithelium maintains normal architecture and uniform nuclear appearance. A biopsy from the proximal esophagus (normal-appearing area) shows normal stratified squamous epithelium. What is the most likely diagnosis in the salmon-pink patch?

Explanation

## Clinical Scenario Analysis ### Key Findings **High-Yield:** The salmon-pink patch in the distal esophagus with columnar epithelium containing goblet cells is pathognomonic for **Barrett's esophagus** — a metaplastic change of the esophageal lining in response to chronic acid reflux. ### Metaplasia in Barrett's Esophagus **Key Point:** Barrett's esophagus represents metaplasia of the normal stratified squamous epithelium of the esophagus to columnar epithelium with intestinal-type differentiation (specialized columnar epithelium with goblet cells). - **Stimulus:** Chronic GERD causes repeated acid injury to the esophageal mucosa - **Adaptive response:** The esophagus replaces the damaged squamous epithelium with more acid-resistant columnar epithelium - **Histology:** Columnar epithelium with goblet cells (intestinal metaplasia) - **Reversibility:** Potentially reversible with aggressive acid suppression, especially if caught early ### Why This Is Metaplasia, Not Dysplasia **Clinical Pearl:** The critical finding is that the epithelium maintains **normal architecture and uniform nuclear appearance**. This is the hallmark of metaplasia without dysplasia. | Feature | Metaplasia (Barrett's without dysplasia) | Dysplasia (Barrett's with dysplasia) | |---------|------------------------------------------|--------------------------------------| | **Epithelial type** | Columnar with goblet cells | Columnar with goblet cells | | **Architecture** | Normal, organized | Disorganized, crowded | | **Nuclear appearance** | Uniform, normal N:C ratio | Irregular, ↑N:C ratio, coarse chromatin | | **Mitotic figures** | Normal location (base) | Abnormal location throughout epithelium | | **Malignant potential** | ~0.2% per year progression to cancer | High risk of progression to adenocarcinoma | | **Management** | PPI therapy, surveillance endoscopy | Endoscopic ablation or resection | ### Pathophysiology of Barrett's Metaplasia **Mnemonic:** **GERD → METAPLASIA → DYSPLASIA → CANCER** 1. **GERD** causes chronic acid injury to squamous epithelium 2. **Metaplasia** (Barrett's): squamous → columnar with goblet cells (adaptive) 3. **Dysplasia**: loss of uniformity, nuclear atypia (pre-malignant) 4. **Adenocarcinoma**: invasion and spread (malignancy) ### Why Not Dysplasia? **Warning:** The question explicitly states "normal architecture and uniform nuclear appearance." These are the defining features of metaplasia without dysplasia. If dysplastic changes were present, the nuclei would be irregular, crowded, and have increased nuclear-to-cytoplasmic ratios. ### Clinical Management of Barrett's Metaplasia **Key Point:** Barrett's esophagus without dysplasia requires: - High-dose proton pump inhibitor (PPI) therapy - Surveillance endoscopy every 3–5 years - Smoking cessation and dietary modification - Assessment for dysplasia at each endoscopy **High-Yield:** The risk of malignant transformation is approximately 0.2–0.5% per year in non-dysplastic Barrett's esophagus. This is why surveillance is essential but endoscopic intervention is not yet indicated.